This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Publication date: Available online 30 November 2023 Source: The American Journal of Cardiology Author(s): Muni Rubens, Venkataraghavan Ramamoorthy, Anshul Saxena, Javier Jimenez, Shebin George, Jiana Baker, Juan Ruiz, Sandra Chaparro
While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.
Journal of the American Heart Association, Volume 12, Issue 23 , December 5, 2023. BackgroundLeft heart disease is the most common cause of pulmonary hypertension (PH) and is frequently accompanied by increases in pulmonary vascular resistance.
Harvard University Heart Letter) A clinical polygenic risk score test for diseases ranging from atrialfibrillation (AFib) to breast cancer was piloted by scientists. JACC: Asia) Lexaria Bioscience has announced that a CBD product beats a placebo in simulating acute pulmonary hypertension.
Participants were recommended to restart therapy post-trial and were followed until May 2023. One third of relapses during follow-up had identifiable triggers (arrhythmia [ n =4], pregnancy [ n =1], hypertension [ n =1], infection [ n =1]). Those randomized to continue therapy subsequently withdrew treatment between 6 and 12months.
Introduction:Clinical characteristics of patients with in-hospital onset stroke (IHOS) compared to those with out-of-hospital onset stroke are reported to be late detection of stroke onset, less use of rt-PA, presence of atrialfibrillation, and poor outcome. Patients under 18 years and discharged within 24 hours were excluded.
Background:The STRACK project aims to improve post-stroke patient management and the transition from acute to primary care thanks to improvements in patient pathways and monitoring cardiovascular risk factors: heart failure, diabetes, atrialfibrillation, dyslipidemia and hypertension.
Ensuring a follow-up neurology appointment within two weeks is vital to managing stroke risk factors like hypertension, diabetes, and atrialfibrillation. The first period, from July 2022 through June 2023, represents the timeframe before the opening of the transition-of-care clinic.
Hypertension, Volume 80, Issue 12 , Page 2572-2580, December 1, 2023. BACKGROUND:The STEP (Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients) trial demonstrated that intensive systolic blood pressure (SBP) lowering has cardiovascular benefits. years, and 46.5% were men.
Our investigation focused on delineating the distinctive features of ICAS-related LVOS to explore its underlying pathology.Methods:This is a cross-sectional comparison from a prospective, single-center cohort study of acute ischemic stroke from January 2017 to January 2023. Among patients with lower fibrinogen levels (< 3.2g/L),
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Patients with poorly controlled diabetes were significantly younger (median age 63 vs 72, p <0.001), had a lower prevalence of atrialfibrillation (7.69% vs 29.8%, p <0.001) and a higher median LDL level (95.5 or greater.
Propensity score-matched analysis (PSM) (1:1) was performed with matching for age, gender, race, BMI, hypertension, diabetes mellitus, chronic kidney disease, hemoglobin level, low-density lipid (LDL) level, left ventricular ejection fraction, and various drugs including ACEi, ARBi, ARNI, beta-blockers, and diuretics.
24 will focus on the following three current guideline updates: American College of Cardiology (ACC)/American Heart Association (AHA) Guidelines 2023AtrialFibrillation Guideline - Pharmacology II: Strokes vs. Bleeds, What Do the Guidelines Tell Us About Practical Management in A-fib? The Guidelines Sessions at ACC.24
Written by Magnus Nossen The patient in today's case is a male in his 70s with hypertension and type II diabetes mellitus. The rhythm now is atrialfibrillation. His wife contacted the ambulance service after the patient experienced an episode of loss of consciousness. The syncope lasted about 2-3 minutes according to his wife.
We aim to study if patients with severe cervical myalgias and FHP have an increased risk of posterior circulation stroke.Methods:We identified all adult patients with posterior circulation stroke and diagnosis of cervical myalgia at Loyola University Medical Center from January 2018 to January 2023. The average C2 tilt of cases was 22.9
Patients with a modified Rankin score of 3-5 were offered enrollment in the Stroke Transitions Program (intervention group). The control group included patients not enrolled in the program. The intervention group had a significantly lower rate of 1 year hospital readmission due to any cause (62.1% vs 69.3%, p=0.04).
Aim:This study investigates the prevalence of isolated interventricular membranous septal (IVMS) aneurysms detected via echocardiography and assesses the associated stroke risk without other classical risk factors.Methods:We searched the echocardiography database at Mount Sinai Morningside from January 2017 to September 2023.
We present our institutional experience with EVT in this patient population.Methods:Prospectively maintained database from our comprehensive stroke center was retrospectively reviewed for consecutive cases from December 2014 to July 2023. Patients who underwent EVT were included.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. vs 40%, p=0.03) and lower rate of atrialfibrillation (12.1% IntroductionThe risk of tandem occlusion treatment in the setting of intravenous thrombolysis is unclear. vs 26.6%, p=0.01).
Image courtesy: Peerbridge Health christine.book Tue, 12/19/2023 - 10:22 December 19, 2023 — Peerbridge Health has announce the successful completion and findings of its prospective, feasibility clinical trial, resulting in a statistically significant 91.2% Studies estimated that identifying and treating every patient in the U.S.
However, treatment strategies for MSS-LVO lack consensus, and a deeper understanding of the natural history of MSS-LVO is needed.Methods:We screened all patients presenting to a large stroke network, from May 2017 to August 2023, for intracranial anterior circulation LVO and MSS (NIHSS %lt 6). years old, with 58.8% black, and 16.2%
The key risk factor for cardioembolic stroke is atrialfibrillation or flutter, and oral anticoagulation (OAC) is recommended in all but the lowest-risk patients with evidence of these arrhythmias. Stroke is a major cause of mortality, morbidity and economic burden. Strokes can be thrombotic, embolic or haemorrhagic.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionAneurysmal subarachnoid hemorrhage (aSAH) accounts for about 10% of hemorrhagic strokes [1] and holds a high mortality and morbidity rate. [2, 2, 3] Vasospasm is one of the more devastating complications of aSAH. He was intubated by EMS on route.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. The patient underwent surgery, but suffered from a gastrointestinal bleed and developed post‐operative atrialfibrillation; after a risks/benefits discussion, he was discharged on anticoagulation only.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrialfibrillation (AF). link] ACC/AHA Release Updated AtrialFibrillation Guidelines for 2023. Sources: Joglar, J, Chung, M. J Am Coll Cardiol.
edits by Meyers A woman in her 60s with a history of chronic atrialfibrillation on Eliquis, ESRD on hemodialysis, type-II diabetes mellitus, prior CVA, hypertension, and hyperlipidemia presented to the emergency department with multiple complaints after missing dialysis. Atrial Flutter with Inferior STEMI?
The rhythm appears to be atrialfibrillation. An old formal echo was found from 6 mo ago: Dilated right ventricle with septal flattening and estimated right ventricular systolic pressure of 70 mmHg (significant pulmonary hypertension). This was texted to me. An 80-something woman who presented with chest pain and dyspnea.
Atrialfibrillation (AF) is a common cardiac dysrhythmia linked to stroke and cardiovascular events. Introduction:Patients with atherosclerotic carotid artery disease are at high risk of mortality in the long-term follow-up after carotid endarterectomy (CEA), partly due to dysrhythmia.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. Hypertension was a common co‐morbidity in half of the population, also diabetes and atrialfibrillation were existing in 1/3 of cases. The use of EVT is known internationally, mostly in the western hemisphere.
We evaluated the adjusted association of collateral status parameters with 90-day post-EVT functional outcomes in AIS patients with LVOs and MeVOs.Methods:We retrospectively evaluated AIS patients treated at our institution between January 9, 2017, and January 10, 2023. Results:A total of 277 LVO (mean age 66.3
mg/kg) were reviewed from 21 hospitals in a large integrated health system between November 2020 to December 2023. of patients, followed by diabetes (58%), hyperlipidemia (55%), atrialfibrillation (20%), and history of stroke (18%). Results:The mean age of the 195 cases was 75.4 (SD SD = 13.46). History of was present in 75.4%
Age, BMI, hypertension, CHA2DS-VASC score, neutrophil to lymphocyte ratio (NLR), LAA volume, LA volume, the myocardial thickness at the junction of LAA and LA, the area, circumference, short diameter, and long diameter of the LAA opening, were significantly different between the AF group and the control group (P<0.05).
A 69 year old woman with a history of hypertension presented to the emergency department by EMS for evaluation of chest pain and shortness of breath. increasing stenosis, ischemia, volume changes, increased blood pressure, atrialfibrillation, etc.) This was written by Hans Helseth. As her pain worsened, so did her dyspnea.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content